NurExone Biologic's total assets for Q4 2025 were $4.08M, an increase of 29.74% from the previous quarter. DE:J90 total liabilities were $1.32M for the fiscal quarter, a 15.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.